ICM
WLY icon

Invenomic Capital Management’s John Wiley & Sons Class A WLY Stock Holding History

Invenomic Capital Management’s Portfolio WLY Stock Details WLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,270
Closed -$866K – 186
2025
Q4 		$866K Buy
+28,270
New +$996K 0.04% 141

Other funds holding WLY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Silvercrest Asset Management
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Invenomic Capital Management's WLY Position: Q1 2026 in Review

Invenomic Capital Management sold out of John Wiley & Sons Class A (WLY) in Q1 2026, closing a stake of 28,270 shares — an estimated $866K sold.

Invenomic Capital Management first reported a position in WLY in Q4 2025 and held it in 1 quarter. The position peaked at $866K in Q4 2025. 249 funds tracked by Wall St. Rank hold WLY as of Q1 2026.

  • Invenomic Capital Management reported no remaining John Wiley & Sons Class A position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 28,270 John Wiley & Sons Class A shares in Q1 2026, an estimated $866K.
  • Invenomic Capital Management first reported a position in John Wiley & Sons Class A in Q4 2025 and held it in 1 quarter.
  • Invenomic Capital Management's John Wiley & Sons Class A position peaked at $866K in Q4 2025.
  • 249 funds tracked by Wall St. Rank held John Wiley & Sons Class A as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.